Back

Learner’s Digest International (TM)

  • Chronic Limb-Threatening Ischemia
  • Diabetic Foot
  • Hemangioma

Best and Basil Trials/Diabetic Foot Ulcers/Vascular Tumors

The goal of this program is to improve the diagnosis and management of chronic limb threatening ischemia (CLTI), use of telemedicine and technology in the prevention of diabetic foot ulcers, and the management of vascular tumors in children. After hearing and assimilating this program, the clinician will be better able to: 1. Explain findings of BEST CLI and BASIL trials comparing surgery with endovascular therapy in patients with CLTI. 2. List contraindications to use of telemedicine among patients with diabetes. 3. Compare management of diabetic foot ulcer using a combination of telemedicine and in-clinic visits with in-clinic care alone. 4. Differentiate among various phases of infantile hemangioma. 5. Formulate a treatment plan for a patient with diffuse hepatic hemangioma.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

ABS — Accredited CMEUp to 2 pointsABS — Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $1,095

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider · audio-digest.org

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Nov 23, 2028 2 years left